A Roadmap for Implementing RBM and Quality Management
The importance of applying change management techniques throughout the preparation, planning, and execution of RBM and RBQM approaches.
With AD Drug Failures, Non-Pharma Efforts Become More Critical
Where pharmaceutical interventions for Alzheimer's falls short, nursing care facilities are relying heavily on non-traditional medicines and physical and mental exercise.
Work Planning & Approaches to Overcome Bottlenecks
Outlining a resource planning and scheduling model, using the example of an analytical department in drug development.
Oncology Pharma De-Risk Through Collaborations, Novel Combination Targets
President and CEO of Cyclacel, Spiro Rombotis, discusses why targeting cyclin-dependent kinases and the DNA repair pathway could enhance care across various oncology indications.
Weaponizing Cancer as a European Election Pledge
As elections near, politicians in Europe make promises to prioritize the fight against cancer.
More Efficient, Informative Clinical Trials Is the Goal of FDA Leaders
FDA leaders urge developers, researchers, and research sponsors to help promote policies and programs to streamline clinical research to develop new medical products at reduced costs.
Relying on Data and Behavior Science to Unlock Real Change
What small “nudges” can serve as reminders and relevant motivators to help patients meet their goals, talk to a physician, explore a clinical trial, or stick with a treatment?
Applied Clinical Trials, May 2019 Issue (PDF)
Click the title above to open the Applied Clinical Trials May 2019 issue in an interactive PDF format.
2 Commerce Drive Cranbury, NJ 08512